Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 3
2012 1
2014 1
2015 5
2016 5
2017 8
2018 11
2019 14
2020 17
2021 9
2022 10
2023 13
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Spatial Extent of Amyloid-β Levels and Associations With Tau-PET and Cognition.
Ozlen H, Pichet Binette A, Köbe T, Meyer PF, Gonneaud J, St-Onge F, Provost K, Soucy JP, Rosa-Neto P, Breitner J, Poirier J, Villeneuve S; Alzheimer’s Disease Neuroimaging Initiative, the Harvard Aging Brain Study, the Presymptomatic Evaluation of Experimental or Novel Treatments for Alzheimer Disease Research Group. Ozlen H, et al. JAMA Neurol. 2022 Oct 1;79(10):1025-1035. doi: 10.1001/jamaneurol.2022.2442. JAMA Neurol. 2022. PMID: 35994280 Free PMC article.
A Head-to-Head Comparison Between Plasma pTau181 and Tau PET Along the Alzheimer's Disease Continuum.
Coomans EM, Verberk IMW, Ossenkoppele R, Verfaillie SCJ, Visser D, Gouda M, Tuncel H, Wolters EE, Timmers T, Windhorst AD, Golla SSV, Scheltens P, van WM, Flier D, van Berckel BNM, Teunissen CE. Coomans EM, et al. Among authors: verfaillie scj. J Nucl Med. 2023 Mar;64(3):437-443. doi: 10.2967/jnumed.122.264279. Epub 2022 Oct 13. J Nucl Med. 2023. PMID: 36229187 Free PMC article.
Performance of a [18F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia With Lewy Bodies.
Coomans EM, de Koning LA, Rikken RM, Verfaillie SCJ, Visser D, den Braber A, Tomassen J, van de Beek M, Collij LE, Lemstra AW, Windhorst AD, Barkhof F, Golla SSV, Visser PJ, Scheltens P, van der Flier WM, Ossenkoppele R, van Berckel BNM, van de Giessen E. Coomans EM, et al. Among authors: verfaillie scj. Neurology. 2023 Nov 7;101(19):e1850-e1862. doi: 10.1212/WNL.0000000000207794. Epub 2023 Sep 25. Neurology. 2023. PMID: 37748892 Free PMC article.
Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia.
Slot RER, Sikkes SAM, Berkhof J, Brodaty H, Buckley R, Cavedo E, Dardiotis E, Guillo-Benarous F, Hampel H, Kochan NA, Lista S, Luck T, Maruff P, Molinuevo JL, Kornhuber J, Reisberg B, Riedel-Heller SG, Risacher SL, Roehr S, Sachdev PS, Scarmeas N, Scheltens P, Shulman MB, Saykin AJ, Verfaillie SCJ, Visser PJ, Vos SJB, Wagner M, Wolfsgruber S, Jessen F; Alzheimer's Disease Neuroimaging Initiative; DESCRIPA working group; INSIGHT-preAD study group; SCD-I working group; van der Flier WM. Slot RER, et al. Among authors: verfaillie scj. Alzheimers Dement. 2019 Mar;15(3):465-476. doi: 10.1016/j.jalz.2018.10.003. Epub 2018 Dec 13. Alzheimers Dement. 2019. PMID: 30555032 Free PMC article.
Neurobiological basis and risk factors of persistent fatigue and concentration problems after COVID-19: study protocol for a prospective case-control study (VeCosCO).
Verveen A, Verfaillie SCJ, Visser D, Csorba I, Coomans EM, Koch DW, Appelman B, Barkhof F, Boellaard R, de Bree G, van de Giessen EM, Golla S, van Heugten CM, Horn J, Hulst HE, de Jong MD, Kuut TA, van der Maaden T, van Os YMG, Prins M, Slooter AJC, Visser-Meily JMA, van Vugt M, van den Wijngaard CC, Nieuwkerk PT, Knoop H, Tolboom N, van Berckel BNM. Verveen A, et al. Among authors: verfaillie scj. BMJ Open. 2023 Jun 30;13(6):e072611. doi: 10.1136/bmjopen-2023-072611. BMJ Open. 2023. PMID: 37399444 Free PMC article.
Precision estimates of relative and absolute cerebral blood flow in Alzheimer's disease and cognitively normal individuals.
Heeman F, Visser D, Yaqub M, Verfaillie S, Timmers T, Pijnenburg YA, van der Flier WM, van Berckel BN, Boellaard R, Lammertsma AA, Golla SS. Heeman F, et al. Among authors: verfaillie s. J Cereb Blood Flow Metab. 2023 Mar;43(3):369-378. doi: 10.1177/0271678X221135270. Epub 2022 Oct 21. J Cereb Blood Flow Metab. 2023. PMID: 36271598 Free PMC article.
77 results